Barbaro Giuseppe
Department of Medical Pathophysiology, University La Sapienza, Rome, Italy.
AIDS. 2003 Apr;17 Suppl 1:S12-20. doi: 10.1097/00002030-200304001-00003.
As longevity increases in HIV-infected individuals after the introduction of highly active antiretroviral therapy regimens, long-term effects such as cardiovascular disease and, more specifically, symptomatic heart failure are emerging as leading health issues. In the present review article, we discuss HIV-associated cardiovascular disease, focusing on etiopathogenetic mechanisms that may play a role in diagnosis, management, and therapy of HIV-associated heart failure in the highly active antiretroviral therapy era.
